Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
- PMID: 28301577
- PMCID: PMC5354437
- DOI: 10.1371/journal.pone.0174493
Correction: Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer
Abstract
[This corrects the article DOI: 10.1371/journal.pone.0171356.].
Erratum for
-
Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer.PLoS One. 2017 Feb 3;12(2):e0171356. doi: 10.1371/journal.pone.0171356. eCollection 2017. PLoS One. 2017. PMID: 28158234 Free PMC article.
References
-
- Takeda T, Yamamoto H, Kanzaki H, Suzawa K, Yoshioka T, Tomida S, et al. (2017) Yes1 signaling mediates the resistance to Trastuzumab/Lap atinib in breast cancer. PLoS ONE 12(2): e0171356 doi:10.1371/journal.pone.0171356 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
